More Part A stays. More places for drug costs to hide.
Rehab-heavy facilities carry the most drug cost inside the Part A rate, and the most exposure when the wrong payer is billed. We reconcile every stay.
What we hear most often.
High-cost drugs inside a fixed rate
Short stays often come with expensive discharge medications. One mis-billed specialty drug can wipe out a stay's margin.
Fast payer changes
Residents move from Part A to Part B, Medicaid or private pay mid-month. Pharmacy billing doesn't always follow.
Overlap is under review
The OIG is reviewing whether SNFs paid for drugs during Part A stays or let Part D pay instead.
The audit, shaped for you.
Same six checks on every line. Reported the way short-stay and rehab facilities need to see it.
- A day-by-day payer timeline for every resident, matched to every invoice line
- Part D billed during Part A stays, listed as compliance exposure with evidence
- Consolidated billing exclusions identified so excluded drugs aren't charged to you
- High-cost drug review with clinical pharmacist sign-off
Insights for short-stay and rehab facilities.
Family-supplied medications during a Part A SNF stay
Why family-supplied medications during a Part A SNF stay create cost and compliance risk, what CMS and the OIG have said, and a safer admissions process.
ReadHigh-cost drugs in a Part A SNF stay: how to plan for them
How to plan for high-cost drugs in a Part A SNF stay: check exclusions, capture NTA payment, price alternatives and avoid family supply before admission.
ReadOIG work plan on SNF drugs in Part A stays: what to expect
The OIG work plan item on SNF drugs during Part A stays, what the 2024 audit found, the records auditors used, and how to prepare your facility now.
ReadRequest your free first look.
Tell us who you are. We'll reply within one business day with a BAA and a secure upload link.